Chargement en cours...
Ifosfamide-Induced Metabolic Encephalopathy in 2 Patients With Cutaneous T-Cell Lymphoma Successfully Treated With Methylene Blue
Ifosfamide, an alkylating agent used in cancer treatments, can cause neurotoxicity. The clinical presentation can range from mild symptoms such as acute confusion to non-convulsive seizures, severe irreversible coma, and death. The benefit of methylene blue use in treating ifosfamide-induced metabol...
Enregistré dans:
| Publié dans: | J Investig Med High Impact Case Rep |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6069036/ https://ncbi.nlm.nih.gov/pubmed/30083561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2324709618786769 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|